The tool you need to monitor the market almost real-time.
December 20, 2022

The tool you need to monitor the market almost real-time.

Anonymous | TrustRadius Reviewer
Score 10 out of 10
Vetted Review
Verified User

Overall Satisfaction with AlphaSense

Proactive researching on drugs within the pharmaceutical area Obtention of investor call transcripts avoid the need to attend digitally to such events Placement of Alphasense alerts enables reactive monitor the landscape easily Easy-to-find clinical trials due to the clinicaltrials.gov tool incorporated into the platform Gathering of the latest guidance from companies on a certain topic quickly.

Pros

  • Reactive alerts to maintain the pulse on the market.
  • Transcripts from investor calls are provided relatively soon after the event.
  • Clinicaltrials.gov tool works well to find updates on latest clinical trials.

Cons

  • A tool that enables access to clinicaltrials.gov directly from an alert to avoid the need to conduct a separate search.
  • Access to health authorities' documents beyond the general ones (EMA, FDA, NMPA, Health Canada, etc.). Japan would be nice to have as well.
  • Efficiency/productivity.
  • Deeper competitive insights.
  • Broader content sources.
  • Guidance from broker research analysts.
I give this rating because the platform has made my life easier, so I am not willing to search for a different tool.
AlphaSense has totally impacted my team's ability to be more aware of the landscape due to the reactive alerts available to obtain relevant insights in almost real time.

Do you think AlphaSense delivers good value for the price?

Yes

Are you happy with AlphaSense's feature set?

Yes

Did AlphaSense live up to sales and marketing promises?

I wasn't involved with the selection/purchase process

Did implementation of AlphaSense go as expected?

Yes

Would you buy AlphaSense again?

Yes

High potential for those employees that require conducting day-to-day drug landscape research.

Comments

More Reviews of AlphaSense